• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

绝经后女性接受17β-雌二醇-地屈孕酮治疗期间撤退性出血模式及子宫内膜组织学的变化:一项为期2年的前瞻性研究。

Changes in the withdrawal bleeding pattern and endometrial histology during 17 beta-estradiol-dydrogesterone therapy in postmenopausal women: a 2 year prospective study.

作者信息

van der Mooren M J, Hanselaar A G, Borm G F, Rolland R

机构信息

Department of Obstetrics and Gynecology, University Hospital Nijmegen Sint Radboud, Nijmegen, The Netherlands.

出版信息

Maturitas. 1994 Dec;20(2-3):175-80. doi: 10.1016/0378-5122(94)90014-0.

DOI:10.1016/0378-5122(94)90014-0
PMID:7715470
Abstract

OBJECTIVE

To describe changes in the withdrawal bleeding pattern and endometrial histology during a sequential 17 beta-estradiol-dydrogesterone regimen in postmenopausal women.

DESIGN

Open-label, non-comparative, prospective study.

SETTING

Gynecological outpatient department of a university hospital.

PATIENTS

Twenty-seven healthy non-hysterectomized postmenopausal women.

INTERVENTIONS

Continuous micronized 17 beta-estradiol supplementation, 2 mg daily, and cyclic administration of dydrogesterone, 10 mg daily for the first half of each 28 day treatment cycle.

MAIN OUTCOME MEASURES

Changes in the characteristics of the withdrawal bleeding pattern and the endometrial biopsy histology during 2 years of treatment.

RESULTS

The initial withdrawal bleeding was comparable to normal menstruation with respect to amount and duration. During the 2 years of treatment the bleeding showed a significant tendency to become shorter with less blood loss. This was mainly the result of the decrease (P < 0.001) in the number of days per cycle with bleeding grade II (normal menstruation). None of the women developed endometrial hyperplasia, and in almost all women the given hormone replacement therapy regimen induced secretory or atrophic changes of the endometrium.

CONCLUSIONS

This sequential 17 beta-estradiol-dydrogesterone regimen can be regarded as safe with respect to the prevention of endometrial disease and appeared to foster patient compliance.

摘要

目的

描述绝经后女性在序贯使用17β-雌二醇-地屈孕酮方案期间撤退性出血模式和子宫内膜组织学的变化。

设计

开放标签、非对照、前瞻性研究。

地点

大学医院妇科门诊。

患者

27名健康的未行子宫切除术的绝经后女性。

干预措施

持续补充微粒化17β-雌二醇,每日2mg,以及周期性给予地屈孕酮,在每个28天治疗周期的前半周期每日10mg。

主要观察指标

治疗2年期间撤退性出血模式特征和子宫内膜活检组织学的变化。

结果

初始撤退性出血在出血量和持续时间方面与正常月经相当。在2年治疗期间,出血呈现出明显的缩短趋势,失血量减少。这主要是由于每个周期中出现Ⅱ级出血(正常月经)的天数减少(P<0.001)。所有女性均未发生子宫内膜增生,并且几乎所有女性使用的激素替代治疗方案均导致子宫内膜出现分泌期或萎缩性变化。

结论

就预防子宫内膜疾病而言,这种序贯17β-雌二醇-地屈孕酮方案可被视为安全的,并且似乎有助于提高患者的依从性。

相似文献

1
Changes in the withdrawal bleeding pattern and endometrial histology during 17 beta-estradiol-dydrogesterone therapy in postmenopausal women: a 2 year prospective study.绝经后女性接受17β-雌二醇-地屈孕酮治疗期间撤退性出血模式及子宫内膜组织学的变化:一项为期2年的前瞻性研究。
Maturitas. 1994 Dec;20(2-3):175-80. doi: 10.1016/0378-5122(94)90014-0.
2
Endometrial histology and bleeding patterns in post-menopausal women taking sequential, combined estradiol and dydrogesterone.接受序贯性雌二醇和地屈孕酮联合治疗的绝经后女性的子宫内膜组织学和出血模式
Maturitas. 1997 Apr;26(3):219-26. doi: 10.1016/s0378-5122(97)01104-3.
3
Comparison of transvaginal ultrasonography and endometrial biopsy in endometrial surveillance in postmenopausal HRT users.经阴道超声检查与子宫内膜活检在绝经后激素替代治疗使用者子宫内膜监测中的比较。
Maturitas. 1997 Jun;27(2):133-43. doi: 10.1016/s0378-5122(97)00037-6.
4
Bleeding patterns and endometrial histology during administration of low-dose estradiol sequentially combined with dydrogesterone.低剂量雌二醇与地屈孕酮序贯联合用药期间的出血模式及子宫内膜组织学
Climacteric. 1999 Jun;2(2):101-9. doi: 10.3109/13697139909025573.
5
Endometrial safety and bleeding patterns during a 2-year study of 1 or 2 mg 17 beta-estradiol combined with sequential 5-20 mg dydrogesterone.在一项为期两年的研究中,1毫克或2毫克17β-雌二醇联合序贯使用5 - 20毫克地屈孕酮时的子宫内膜安全性和出血模式。
Climacteric. 2002 Mar;5(1):26-35.
6
Endometrial safety of continuous combined hormone replacement therapy with 17beta-oestradiol (1 or 2 mg) and dydrogesterone.17β-雌二醇(1毫克或2毫克)与地屈孕酮连续联合激素替代疗法的子宫内膜安全性
Maturitas. 2001 Jan 31;37(3):191-9. doi: 10.1016/s0378-5122(00)00176-6.
7
A dose-ranging study of the use of cyclical dydrogesterone with continuous 17 beta oestradiol.一项关于周期性地屈孕酮与持续使用17β-雌二醇联合应用的剂量范围研究。
Br J Obstet Gynaecol. 1995 Mar;102(3):243-8. doi: 10.1111/j.1471-0528.1995.tb09102.x.
8
Endometrial response in estrogen replacement therapy quarterly combined with a progestogen.雌激素替代疗法联合孕激素每季度应用时的子宫内膜反应。
Maturitas. 1996 May;24(1-2):63-71. doi: 10.1016/0378-5122(95)01020-3.
9
Can endometrial protection be inferred from the bleeding pattern on combined cyclical hormone replacement therapy.能否从联合周期性激素替代疗法的出血模式推断子宫内膜保护作用?
Maturitas. 2000 Feb 15;34(2):155-60. doi: 10.1016/s0378-5122(99)00101-2.
10
Estradiol and dydrogesterone. A review of their combined use as hormone replacement therapy in postmenopausal women.雌二醇和地屈孕酮。关于它们联合用作绝经后女性激素替代疗法的综述。
Drugs Aging. 1997 Oct;11(4):309-32. doi: 10.2165/00002512-199711040-00006.

引用本文的文献

1
Estradiol and dydrogesterone. A review of their combined use as hormone replacement therapy in postmenopausal women.雌二醇和地屈孕酮。关于它们联合用作绝经后女性激素替代疗法的综述。
Drugs Aging. 1997 Oct;11(4):309-32. doi: 10.2165/00002512-199711040-00006.